triethylenemelamine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MARTIN, H | 1 |
| ASTALDI, G | 1 |
| MASSA, B | 1 |
2 other studies available for triethylenemelamine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
[Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
Topics: Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Triethylenemelamine; Uremia | 1953 |
The influence of triethylenmelamine on the osmotic fragility of surviving leukocytes from chronic lymphatic leukaemia.
Topics: Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukocytes; Osmotic Fr | 1958 |